BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1554 related articles for article (PubMed ID: 24905636)

  • 21. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
    Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
    Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway.
    Cai F; Zhang Y; Li J; Huang S; Gao R
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway.
    Kou B; Liu W; He W; Zhang Y; Zheng J; Yan Y; Zhang Y; Xu S; Wang H
    Oncol Rep; 2016 May; 35(5):2880-6. PubMed ID: 26935264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.
    Aroui S; Aouey B; Chtourou Y; Meunier AC; Fetoui H; Kenani A
    Chem Biol Interact; 2016 Jan; 244():195-203. PubMed ID: 26721195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
    Yang Q; Ji M; Guan H; Shi B; Hou P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells.
    Wei PL; Tu CC; Chen CH; Ho YS; Wu CT; Su HY; Chen WY; Liu JJ; Chang YJ
    J Agric Food Chem; 2013 Aug; 61(34):8191-7. PubMed ID: 23899086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
    Liu WH; Chang LS
    J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of EGF-induced migration and invasion by sulfated polysaccharide of Sepiella maindroni ink via the suppression of EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells.
    Jiang W; Tian W; Ijaz M; Wang F
    Biomed Pharmacother; 2017 Nov; 95():95-102. PubMed ID: 28830011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells.
    Lin KL; Tsai PC; Hsieh CY; Chang LS; Lin SR
    Chem Biol Interact; 2011 Nov; 194(2-3):148-58. PubMed ID: 22033475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pipoxolan inhibits CL1-5 lung cancer cells migration and invasion through inhibition of MMP-9 and MMP-2.
    Lee MM; Chen YY; Liu PY; Hsu S; Sheu MJ
    Chem Biol Interact; 2015 Jul; 236():19-30. PubMed ID: 25899827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway.
    Hung SH; Shen KH; Wu CH; Liu CL; Shih YW
    J Agric Food Chem; 2009 Feb; 57(4):1291-8. PubMed ID: 19178296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression.
    Zhang J; Zhu X; Li H; Li B; Sun L; Xie T; Zhu T; Zhou H; Ye Z
    Int Immunopharmacol; 2015 Jan; 24(1):50-8. PubMed ID: 25479727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadmium induces matrix metalloproteinase-9 expression via ROS-dependent EGFR, NF-кB, and AP-1 pathways in human endothelial cells.
    Lian S; Xia Y; Khoi PN; Ung TT; Yoon HJ; Kim NH; Kim KK; Jung YD
    Toxicology; 2015 Dec; 338():104-16. PubMed ID: 26514923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
    Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
    Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-metastatic effect of rhodomyrtone from Rhodomyrtus tomentosa on human skin cancer cells.
    Tayeh M; Nilwarangoon S; Mahabusarakum W; Watanapokasin R
    Int J Oncol; 2017 Mar; 50(3):1035-1043. PubMed ID: 28075447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.
    Zhao Q; Assimopoulou AN; Klauck SM; Damianakos H; Chinou I; Kretschmer N; Rios JL; Papageorgiou VP; Bauer R; Efferth T
    Oncotarget; 2015 Nov; 6(36):38934-51. PubMed ID: 26472107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.